About: Northwest Clinical Research Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Northwest Clinical Research Center Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

facility in Bellevue, United States

Attributes	Values
rdf:type	Item
description	facility in Bellevue, United States (en)
rdfs:label	Northwest Clinical Research Center (en)
skos:prefLabel	Northwest Clinical Research Center (en)
name	Northwest Clinical Research Center (en)
ROR ID	wds:Q30282378-A0414599-BCA5-4406-BDCD-0F4BED93EE36
ROR ID	00phd3t88
instance of	wds:Q30282378-B834328B-3AC3-4C18-AA25-EFE6C04C88E4
instance of	facility
country	wds:Q30282378-CD06D853-862B-4D41-969F-752BABB56030
country	United States of America
Ringgold ID	wds:Q30282378-167CD1F0-93CD-4C36-A65B-4F6D4C8CE622
Ringgold ID	375079
inception	wds:Q30282378-2E9B609C-4325-4E7C-B4C1-332DDCF62942
inception	1995-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	NWCRC (en)
located in the adm...erritorial entity	wds:Q30282378-09E6A2B9-C762-4422-923D-409250BB4F9F
ISNI	wds:Q30282378-CDB0CFAE-686F-4458-8516-F6C295B5B9F1
coordinate location	wds:Q30282378-F153AC17-E649-44D1-B62A-E895B65AFA3D
official website	wds:Q30282378-37243AC9-FA2E-46DA-A7F2-C5EEA8716366
located in the adm...erritorial entity	Bellevue
ISNI	0000000417963946
coordinate location	POINT(-122.13708 47.627642)
official website	http://nwcrc.net/
GRID ID	wds:Q30282378-2DB8AC47-FCD8-4E92-8DF6-75D79C2F55E8
GRID ID	grid.420102.5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30282378
is research site of	Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD A Study of Lasmiditan (LY573144) Over Four Migraine Attacks Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD Trial in Adult Subjects With Acute Migraines A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl A Study of LY3154207 in Participants With Parkinson's Disease Dementia Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidep AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain Study of COR388 HCl in Subjects With Alzheimer's Disease A Study of Aripiprazole in Patients With Major Depressive Disorder BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine POC Study in Partially Responsive Generalized Anxiety Disorder Safety and Efficacy Study in Adult Subjects With Acute Migraines Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD) Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia PRC-063 in Adolescent ADHD Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression Randomized Trial of Adult Subjects With Generalized Anxiety Disorder Experimental Medication For the Treatment of Generalized Anxiety Disorder Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome Open Label Safety Study in Acute Treatment of Migraine Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study Major Depressive Disorder With Mixed Features A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder Escitalopram for Agitation in Alzheimer's Disease A Study of LY2623091 in Participants With High Blood Pressure Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee Study of Rapastinel as Monotherapy in Patients With MDD Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. Efficacy and Safety of SPD503 in Combination With Psychostimulants Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software